Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MG1109 egg-based pre-pandemic H5N1 influenza vaccine in healthy adults
KCT0001027Phase 3Completed
- Sponsor
- Korea Disease Control and Prevention Agency
- Start
- Aug 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of MG1109 in avian influenza (HPAI) (2 arms), sponsored by Korea Disease Control and Prevention Agency. Started Aug 2013; status: completed.
02
Drugs
MG1109
03
Conditions
avian influenza (HPAI)
Beyond the preview
Go deeper on KCT0001027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001027.